Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

PDT Said to Cut Risk of Vision Loss in Some AMD Patients
Oct 1999
BALTIMORE, Oct. 19 - A treatment regimen combining lasers and a light-sensitive medication appears to reduce the risk of vision loss in some patients with age-related macular degeneration, or AMD, according to a study of more than 600 patients at 22 medical centers across North America and Europe. In the study, led by Johns Hopkins University, researchers found that photodynamic therapy (PDT) reduced the risk of vision loss in certain patients with an aggressive wet form of macular degeneration in which abnormal leaky blood vessels and scar tissue grow across the center of the retina or light-sensitive portion of the eye. Results of the study can be found in the October issue of the journal Archives of Ophthalmology.

News & Featureslasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.